“Eyeballing Cannabis: The Dangers of Guesswork in Dosing”
{ "@context": "https://schema.org", "@type": [ "Article", "MedicalWebPage" ], "headline": "\"Eyeballing Cannabis: The Dangers of Guesswork in Dosing\"",…
The Endocannabinoid System Helps Regulate Neural Signals
{ "@context": "https://schema.org", "@type": [ "Article", "MedicalWebPage" ], "headline": "The Endocannabinoid System Helps Regulate Neural Signals", "articleBody": "The…
HPLC Analyses of CBD Oral Formulation Content Recovery Under Simulated Biological Conditions
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
DEA readies list of cannabis businesses that applied for federal protections (Newsletter: October 29, 2026)
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
Controlling the uncontrollable? navigating naturalistic and controlled dosing in cannabis research
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
In vivo blood and ex vivo brain solid-phase microextraction coupled with LC-MS/MS for mapping unbound cannabidiol, phase I metabolites, and endocannabinoid tone
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
Chatbots and beyond: transforming cannabis use interventions with innovative AI approaches
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
Cannabinoid Therapeutics vs. Recreational Use: A Clinical Conundrum
{ "@context": "https://schema.org", "@type": [ "Article", "MedicalWebPage" ], "headline": "\"Cannabinoid Therapeutics vs. Recreational Use: A Clinical Conundrum\"",…
MindRank AI Targets Selective CB1 Receptor Modulation With Novel Heterocyclic Compounds
The patent disclosure describes novel synthetic heterocyclic molecules engineered to selectively regulate cannabinoid CB1 receptor activity. Developed utilizing computational drug design, these active pharmaceutical ingredients aim to fine-tune receptor…
Trump says cannabis is bad for health, at least for Bill Maher (Newsletter: October 27, 2026)
cannabis news digest: A structured CED Clinic overview of 3 key developments in cannabis regulation, market milestones, and scientific research. It keeps the evidence readable for patients and clinicians. The main study limits remain important for…
